Find policies, billing codes, payers, states, and providers
Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy: Inpatient Reimbursement Overview
DRG 735 covers pelvic evisceration, radical hysterectomy, and radical vulvectomy cases without Major Complication or Comorbidity or Complication or Comorbidity and defines the clinical scope of high-complexity pelvic oncologic surgery. This Diagnosis-Related Group matters for inpatient reimbursement because procedure selection and documentation of comorbid conditions determine grouping and associated Medicare payment.
Customize your policy alerts
Sign up for Pelvic Evisceration, Radical Hysterectomy and Radical Vulvectomy: Inpatient Reimbursement Overview policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
DRG 735 Overview
DRG 735 encompasses extensive pelvic oncologic resections including pelvic evisceration, radical hysterectomy, and radical vulvectomy performed without a Major Complication or Comorbidity and without a Complication or Comorbidity. These procedures are high-complexity, often multidisciplinary surgeries for advanced gynecologic malignancy or refractory pelvic disease. For Medicare payment, this Diagnosis-Related Group groups cases of comparable resource use and sets inpatient reimbursement parameters tied to the principal procedure and absence of higher-severity diagnoses. Accurate coding of procedures and comorbidity status determines assignment to this Diagnosis-Related Group and affects the hospital’s inpatient prospective payment.